This study utilizes the use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial Atherosclrosis
Principal Investigator: Dr. Mohamed Zayed Study Coordinator: Kelley Chadwick-Mansker
This study is currently enrolling participants. To learn more about CCR2 and how you can join contact our research office at (314) 289-7690
This is a joint study with the St. Louis VA and Washington University. The Foundation funds this study through the NIH (National Institute of Health).